Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non‐small cell lung cancer and brain metastases receiving whole‐brain radiotherapy
Jianan Ni, Yuefeng Lu, Haoli Xu, Xuni Xu, Mengjing Zhao, Yingnan Xue et al. Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non‐small cell lung cancer and brain metastases receiving whole‐brain radiotherapy. // Precision Radiation Oncology. – 2026. – DOI: 10.1002/pro6.70077. – URL: https://onlinelibrary.wiley.com/doi/10.1002/pro6.70077?af=R
Jianan Ni, Yuefeng Lu, Haoli Xu, Xuni Xu, Mengjing Zhao, Yingnan Xue, Gang Li, & Yuxia Duan (2026). Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non‐small cell lung cancer and brain metastases receiving whole‐brain radiotherapy. Precision Radiation Oncology. https://doi.org/10.1002/pro6.70077
Jianan Ni, et al. “Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non‐small cell lung cancer and brain metastases receiving whole‐brain radiotherapy.” Precision Radiation Oncology, 2026. doi:10.1002/pro6.70077.
@article{Ni2026,
title = {Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non‐small cell lung cancer and brain metastases receiving whole‐brain radiotherapy},
author = {Ni, Jianan and Lu, Yuefeng and Xu, Haoli and Xu, Xuni and Zhao, Mengjing and Xue, Yingnan and Li, Gang and Duan, Yuxia},
journal = {Precision Radiation Oncology},
year = {2026},
doi = {10.1002/pro6.70077},
url = {https://onlinelibrary.wiley.com/doi/10.1002/pro6.70077?af=R}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment